PEN Penumbra, Inc. Common Stock
NYSE · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 30, 2026
$317.55
· of 52w range
· above low
· to high
$221.2652w low
$362.4152w high
Market Cap
$12.46B
P/E (TTM)
78.0
EPS (TTM)
$4.07
Revenue (TTM)
$1.50B
your badges
52W Range
$221–$362
Analyst Rating
HOLD
Price Target
$362
P/E
78.0
ROE
11.4%
Net Profit Margin
10.7%
Your badge strip is empty — pin a metric anywhere on this page.
PEN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$317.55
Market Cap
$12.46B
P/E (TTM)
78.0
EPS (TTM)
$4.07
Revenue (TTM)
$1.50B
ROE (TTM)
11.4%
52W Range
$221–$362
PEN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About Penumbra, Inc. Common Stock Company overview from Wikipedia
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end.
History
Penumbra was founded in 2004 and manufactures several medical devices but specializes in the neuro/vascular market and creates devices that help treat aneurysms and ischemic stroke.
In 2014, Penumbra launched its Apollo system, a device that “enables minimally invasive removal of deeply seated tissue and fluids in the brain,” allowing for otherwise inoperable blood clots to be removed.
In 2015 the company issued an initial public offering on the New York Stock Exchange. In 2018 the company acquired 40% of the outstanding shares of virtual reality joint venture MVI Health. In 2017 the company acquired the Italian distributor Crossmed.
Criticism
Criticism of Penumbra has followed various aspects of its products and business practices. In 2016 a lawsuit claimed the Penumbra Coil 400 caused brain damage after surgery. The company's specialized catheter has been linked to the deaths of stroke patients, and it was a target of stock short sellers in 2020. According to the Foundation for Financial Journalism, this is a significant dilemma.
A request has been sent to The SEC and U.S. Food and Drug Administration to launch an investigation. A scientist who has published research articles showing the reliability of Penumbra's medical products is (allegedly) an internet fabrication.
Recalls
In 2011 the company recalled its Penumbra Coil 400. In 2017 the company recalled a 3D revascularization device. In 2020 the company recalled one of its catheter used during heart surgery due to increased risk of mortality and serious injury.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
sectorHealth Care
industryHealth Care
employees4,700
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$1.40B2018-12-31 → 2025-12-31
EPS$4.522018-12-31 → 2025-12-31
Free Cash Flow$175M2018-12-31 → 2025-12-31
Net margin10.7%2018-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | PEN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 78.05Y avg ≈-312.0 | ≈-312.0 | 23.8 | Overvalued | |
| P/S | 8.95Y avg ≈10.0 | ≈10.0 | 3.9 | Overvalued | |
| P/B | 8.75Y avg ≈8.9 | ≈8.9 | 4.6 | Overvalued | |
| Price / FCF | 71.25Y avg ≈-157.5 | ≈-157.5 | · | · | |
| Price / Cash Flow | 52.25Y avg ≈237.9 | ≈237.9 | 17.3 | Overvalued | |
| Price / Tangible Book | 9.95Y avg ≈11.2 | ≈11.2 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | PEN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 67.8%5Y avg ≈64.3% | ≈64.3% | 62.3% | Top tier | |
| Operating Margin (TTM) | 12.4%5Y avg ≈4.2% | ≈4.2% | 14.5% | Weak | |
| EBITDA Margin (TTM) | 13.6%5Y avg ≈6.4% | ≈6.4% | 14.5% | Weak | |
| Pretax Margin (TTM) | 13.5%5Y avg ≈4.6% | ≈4.6% | 12.6% | Weak | |
| Net Profit Margin (TTM) | 10.7%5Y avg ≈4.6% | ≈4.6% | 9.8% | Weak | |
| ROA (TTM) | 8.8%5Y avg ≈3.6% | ≈3.6% | 7.8% | Top tier | |
| ROE (TTM) | 11.4%5Y avg ≈4.5% | ≈4.5% | 13.1% | In line | |
| ROIC | 11.5%5Y avg ≈3.8% | ≈3.8% | 9.9% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | PEN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 5.75Y avg ≈5.9 | ≈5.9 | 2.2 | Strong liquidity | |
| Quick Ratio | 2.15Y avg ≈2.2 | ≈2.2 | 1.1 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | PEN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 17.5%5Y avg ≈20.4% | ≈20.4% | · | · | |
| Revenue CAGR 3Y | 18.3%5Y avg ≈19.6% | ≈19.6% | · | · | |
| Revenue CAGR 5Y | 20.2% | · | · | · | |
| EPS YoY | 1155.6% | · | · | · | |
| Net Income YoY | 1168.1% | · | · | · | |
| EPS CAGR 3Y | 37.0% | · | · | · | |
| Net Income CAGR 3Y | 38.4% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | PEN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.85Y avg ≈0.7 | ≈0.7 | 0.6 | Top tier | |
| Inventory Turnover | 1.15Y avg ≈1.1 | ≈1.1 | 1.8 | Weak | |
| Receivables Turnover | 7.85Y avg ≈6.0 | ≈6.0 | 5.8 | Top tier | |
| Revenue / Employee | ≈$298.7K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-2.4%
Next Report
Nov 03, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Jul 27, 2026 | $0.88 | $1.20 | -26.6% |
| March 31, 2026 | $0.82 | $1.09 | -24.5% | |
| Dec. 31, 2025 | $1.18 | $1.12 | 5.0% | |
| Sept. 30, 2025 | $0.97 | $0.93 | 4.2% | |
| June 30, 2025 | $0.86 | $0.83 | 3.6% | |
| March 31, 2025 | $0.83 | $0.67 | 23.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.40B | $1.19B | $1.06B | $847M | $748M | $560M | $547M | · | $334M | $263M | |
| Cost of Revenue | $461M | $440M | $376M | $312M | $272M | $222M | $175M | · | $117M | $92M | |
| Gross Profit | $942M | $755M | $683M | $535M | $475M | $338M | $372M | · | $217M | $171M | |
| R&D Expense | · | · | · | · | · | · | · | · | $32M | $24M | |
| SG&A Expense | $663M | $574M | $506M | $450M | $378M | $287M | $273M | · | $184M | $148M | |
| Operating Expenses | $753M | $746M | $609M | $529M | $483M | $377M | $324M | · | $216M | $172M | |
| Operating Income | $189M | $9M | $74M | $6M | $-8M | $-39M | $48M | · | $1M | $-1M | |
| Interest Expense | · | · | $2M | $2M | $2M | · | · | · | · | · | |
| Interest Income | $16M | $14M | $7M | $2M | $3M | · | · | · | · | · | |
| Other Non-op | $893.0K | $-682.0K | $1M | $-2M | $-4M | $-343.0K | $-227.0K | · | $-1M | $-2M | |
| Pretax Income | $205M | $21M | $80M | $4M | $-11M | $-38M | $50M | · | $2M | $-869.0K | |
| Income Tax | $27M | $7M | $-11M | $6M | $-13M | $-19M | $3M | · | $-4M | $-16M | |
| Net Income | $178M | $14M | $91M | $-2M | $5M | $-16M | $48M | · | $5M | $15M | |
| EPS (Basic) | $4.57 | $0.36 | $2.37 | $-0.05 | $0.14 | $-0.44 | $1.39 | · | $0.14 | $0.49 | |
| EPS (Diluted) | $4.52 | $0.36 | $2.32 | $-0.05 | $0.14 | $-0.44 | $1.34 | · | $0.13 | $0.44 | |
| Shares (Basic) | 38,918,493 | 38,633,744 | 38,401,171 | 37,841,874 | 36,764,290 | 35,766,892 | 34,750,706 | · | 32,978,065 | 30,464,583 | |
| Shares (Diluted) | 39,291,828 | 39,268,037 | 39,216,564 | 37,841,874 | 37,881,180 | 35,766,892 | 36,265,999 | · | 35,319,103 | 33,478,078 | |
| EBITDA | $207M | $33M | $101M | $30M | $9M | $-26M | $56M | · | $5M | $950.0K |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $187M | $324M | $167M | $70M | $59M | $70M | $73M | · | $51M | $13M | |
| Short-term Investments | · | · | · | · | · | $195M | $117M | · | $164M | $116M | |
| Receivables | $190M | $168M | $202M | $203M | $134M | $115M | $106M | · | $58M | $43M | |
| Inventory | $432M | $407M | $388M | $334M | $264M | $220M | $153M | · | $95M | $73M | |
| Prepaid Expense | $50M | $37M | $36M | $30M | $29M | $19M | $15M | $12M | $15M | $19M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $7M | $9M | |
| Current Assets | $1.22B | $951M | $915M | $756M | $681M | $618M | $463M | $410M | $382M | $264M | |
| PP&E (Net) | $117M | $63M | $73M | $65M | $59M | $48M | $52M | · | $31M | $21M | |
| PP&E (Gross) | $194M | $137M | $132M | $113M | $97M | $78M | $73M | · | $41M | $28M | |
| Accum. Depreciation | $77M | $74M | $60M | $48M | $38M | $30M | $21M | · | $11M | $7M | |
| Goodwill | $167M | $166M | $166M | $166M | $166M | $8M | $8M | · | $8M | $0 | |
| Intangibles | $6M | $7M | $71M | $81M | $91M | $11M | $25M | · | $24M | $0 | |
| Other Non-current Assets | $41M | $41M | $26M | $13M | $13M | $9M | $3M | · | $1M | $487.0K | |
| Total Assets | $1.83B | $1.53B | $1.56B | $1.37B | $1.24B | $823M | $666M | $558M | $477M | $308M | |
| Accounts Payable | $35M | $31M | $27M | $27M | $13M | $14M | $15M | · | $7M | $4M | |
| Accrued Liabilities | $132M | $112M | $111M | $106M | $100M | $86M | $68M | $58M | $45M | $32M | |
| Current Liabilities | $183M | $158M | $151M | $145M | $123M | $106M | $91M | $70M | $52M | $36M | |
| Capital Leases | $183M | $187M | $197M | $199M | $137M | $44M | $47M | $47M | · | · | |
| Deferred Tax | · | · | · | · | · | · | $4M | · | $3M | $824.0K | |
| Other Non-current Liabilities | $12M | $15M | $5M | $3M | $4M | $8M | $15M | · | $18M | $824.0K | |
| Total Liabilities | $399M | $382M | $377M | $372M | $290M | $185M | $180M | $135M | $76M | $42M | |
| Common Stock | $39.0K | $38.0K | $39.0K | $38.0K | $37.0K | $36.0K | $35.0K | · | $33.0K | $31.0K | |
| Paid-in Capital | $1.19B | $1.10B | $1.05B | $963M | $911M | $598M | $431M | · | $397M | $274M | |
| Retained Earnings | $238M | $60M | $135M | $44M | $46M | $41M | $58M | · | $2M | $-3M | |
| AOCI | $4M | $-6M | $-3M | $-8M | $-3M | $3M | $-2M | · | $2M | $-5M | |
| Stockholders' Equity | $1.43B | $1.15B | $1.18B | $999M | $954M | $638M | $486M | · | $400M | $267M | |
| Liabilities + Equity | $1.83B | $1.53B | $1.56B | $1.37B | $1.24B | $823M | $666M | $558M | $477M | $308M | |
| Shares Outstanding | 39,229,670 | 38,490,836 | 38,681,549 | 38,107,977 | 37,578,483 | 36,414,732 | 35,001,581 | · | 33,685,146 | 31,108,828 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $17M | $24M | $27M | $24M | $16M | $13M | $8M | · | $4M | $2M | |
| Stock-based Comp | $59M | $46M | $51M | $37M | $66M | $26M | $21M | · | $18M | $15M | |
| Deferred Tax | $21M | $-16M | $-25M | $1M | $-15M | $-20M | $1M | · | $-5M | $-13M | |
| Amort. of Intangibles | $712.0K | $5M | $10M | $9M | $3M | $1M | $1M | · | $418.0K | $0 | |
| Restructuring | · | $5M | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-37M | $101M | $-46M | $-116M | $-63M | $-36M | $-53M | · | $-9M | $-32M | |
| Operating Cash Flow | $239M | $168M | $97M | $-56M | $10M | $-33M | $27M | · | $13M | $-13M | |
| CapEx | $64M | $21M | $15M | $19M | $21M | $25M | $22M | · | $13M | $14M | |
| Investing Cash Flow | $-405M | $78M | $-16M | $55M | $-22M | $-104M | $-13M | · | $-78M | $687.0K | |
| Stock Issued | · | · | · | $0 | $0 | $135M | $0 | · | $106M | $0 | |
| Stock Repurchased | $0 | $100M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $0 | $-100M | · | $0 | $0 | $135M | $0 | · | $106M | · | |
| Financing Cash Flow | $27M | $-87M | $16M | $12M | $836.0K | $135M | $-9M | · | $104M | $7M | |
| Net Change in Cash | $-138M | $157M | $98M | $10M | $-10M | $-3M | $5M | · | $37M | $-6M | |
| Taxes Paid | $15M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $175M | $147M | $82M | $-75M | $-12M | $-58M | $5M | · | $159.0K | $-26M | |
| Levered FCF | · | · | $80M | · | · | · | · | · | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.1% | 63.2% | 64.5% | 63.2% | 63.6% | 60.3% | 68.0% | · | 65.1% | 64.9% | |
| Operating Margin | 13.5% | 0.78% | 7.0% | 0.72% | -1.0% | -7.0% | 8.7% | · | 0.35% | -0.51% | |
| Net Margin | 12.7% | 1.2% | 8.6% | -0.24% | 0.71% | -2.8% | 8.8% | · | 1.4% | 5.6% | |
| Pretax Margin | 14.6% | 1.8% | 7.5% | 0.46% | -1.4% | -6.8% | 9.2% | · | 0.74% | -0.33% | |
| EBITDA Margin | 14.7% | 2.8% | 9.5% | 3.6% | 1.2% | -4.7% | 10.2% | · | 1.5% | 0.36% | |
| ROA | 10.6% | 0.91% | 6.2% | -0.15% | 0.49% | -2.1% | 7.9% | · | 1.2% | 4.8% | |
| ROE | 13.1% | 1.2% | 8.0% | -0.20% | 0.64% | -2.8% | 10.7% | · | 1.4% | 5.6% | |
| ROIC | 11.5% | 0.54% | 7.1% | -0.31% | 0.20% | -3.1% | 9.2% | · | 0.72% | 8.6% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | 6.0 | 6.1 | 5.2 | 5.5 | 5.8 | 5.1 | · | 7.4 | 7.4 | |
| Quick Ratio | 2.1 | 3.1 | 2.4 | 1.9 | 1.6 | 3.6 | 3.2 | · | 5.3 | 4.8 | |
| Interest Coverage | · | · | 42.3 | · | · | · | · | · | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.8 | 0.7 | 0.6 | 0.7 | 0.8 | 0.9 | · | 0.9 | 0.9 | |
| Inventory Turnover | 1.1 | 1.1 | 1.0 | 1.0 | 1.1 | 1.2 | 1.3 | · | 1.4 | 1.4 | |
| Receivables Turnover | 7.8 | 6.5 | 5.2 | 5.0 | 5.5 | 5.1 | 5.8 | · | 6.6 | 7.2 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $36.39 | $29.90 | $30.48 | $26.21 | $25.38 | $17.62 | $13.88 | · | $11.89 | $8.57 | |
| Revenue / Share | $35.72 | $30.42 | $26.99 | $22.39 | $19.74 | $15.67 | $15.09 | · | $9.45 | $7.87 | |
| Cash Flow / Share | $6.07 | $4.29 | $2.48 | $-1.47 | $0.25 | $-0.93 | $0.73 | · | $0.36 | $-0.38 | |
| Cash / Share | $4.76 | $8.43 | $4.33 | $1.83 | $1.58 | $1.91 | $2.08 | · | $1.50 | $0.43 | |
| EPS (TTM) | $4.52 | $0.36 | $2.32 | $-0.05 | $0.14 | $-0.44 | $1.34 | · | $0.13 | $0.44 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 17.5% | 12.9% | 24.9% | 13.3% | 33.4% | · | · | · | · | · | |
| Revenue CAGR 3Y | 18.3% | 16.9% | 23.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 20.2% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 1155.6% | -84.5% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 37.0% | · | · | · | · | · | · | · | · | |
| Net Income YoY | 1168.1% | -84.6% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 38.4% | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.40B | $1.19B | $1.06B | $847M | $748M | $560M | $547M | · | $334M | $263M | |
| Net Income TTM | $178M | $14M | $91M | $-2M | $5M | $-16M | $48M | · | $5M | $15M | |
| Market Cap | $12.20B | $9.14B | $9.73B | $8.48B | $10.80B | $6.37B | $5.75B | · | $3.17B | $1.98B | |
| P/E | 68.8 | 659.7 | 108.4 | -4449.2 | 2052.3 | -397.7 | 122.6 | · | 723.8 | 145.0 | |
| P/S | 8.7 | 7.7 | 9.2 | 10.0 | 14.4 | 11.4 | 10.5 | · | 9.5 | 7.5 | |
| P/B | 8.5 | 7.9 | 8.3 | 8.5 | 11.3 | 9.9 | 11.8 | · | 7.9 | 7.4 | |
| P / Tangible Book | 9.7 | 9.3 | 10.3 | 11.3 | 15.5 | 10.3 | · | · | · | · | |
| P / Cash Flow | 51.1 | 54.3 | 100.0 | -152.3 | 1136.3 | -191.7 | 215.7 | · | 249.8 | -155.0 | |
| P / FCF | 69.7 | 62.1 | 118.5 | -113.1 | -924.6 | -109.9 | 1265.6 | · | 19935.7 | -75.1 | |
| Earnings Yield | 1.5% | 0.15% | 0.92% | -0.02% | 0.05% | -0.25% | 0.82% | · | 0.14% | 0.69% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $390M | $375M | $385M | $355M | $339M | $324M | $316M | $301M | $299M | $279M | $285M | $271M | $261M | $241M | $221M | $214M | |
| Cost of Revenue | $125M | $121M | $123M | $114M | $115M | $108M | $105M | $101M | $137M | $98M | $98M | $93M | $95M | $90M | $83M | $78M | |
| Gross Profit | $265M | $253M | $262M | $240M | $224M | $216M | $211M | $200M | $163M | $181M | $187M | $178M | $167M | $151M | $138M | $135M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | $22M | $20M | · | $21M | |
| SG&A Expense | $199M | $193M | $181M | $169M | $160M | $153M | $148M | $140M | $142M | $144M | $130M | $126M | $127M | $123M | $116M | $109M | |
| Operating Expenses | $224M | $215M | $203M | $192M | $183M | $176M | $168M | $165M | $244M | $169M | $152M | $165M | $149M | $143M | $134M | $130M | |
| Operating Income | $41M | $38M | $59M | $49M | $41M | $40M | $43M | $35M | $-81M | $12M | $35M | $13M | $18M | $8M | $5M | $5M | |
| Interest Expense | · | · | · | · | · | · | · | · | $344.0K | $402.0K | · | · | $444.0K | $416.0K | · | · | |
| Interest Income | $6M | $5M | $5M | $4M | $4M | $3M | $3M | $3M | $4M | $3M | $3M | $2M | $1M | $970.0K | · | · | |
| Other Non-op | $-456.0K | $-1M | $171.0K | $-535.0K | $812.0K | $445.0K | $-1M | $1M | $-226.0K | $-366.0K | $559.0K | $-444.0K | $808.0K | $90.0K | $2M | $-2M | |
| Pretax Income | $46M | $42M | $64M | $52M | $45M | $44M | $44M | $40M | $-78M | $15M | $38M | $13M | $20M | $9M | $7M | $3M | |
| Income Tax | $11M | $9M | $16M | $6M | $0 | $5M | $11M | $10M | $-18M | $4M | $-16M | $4M | $576.0K | $90.0K | $3M | $5M | |
| Net Income | $35M | $33M | $47M | $46M | $45M | $39M | $34M | $30M | $-60M | $11M | $54M | $9M | $19M | $9M | $4M | $-2M | |
| EPS (Basic) | $0.88 | $0.83 | $1.21 | $1.17 | $1.17 | $1.02 | $0.87 | $0.76 | $-1.55 | $0.28 | $1.42 | $0.24 | $0.49 | $0.22 | $0.11 | $-0.06 | |
| EPS (Diluted) | $0.88 | $0.82 | $1.20 | $1.17 | $1.15 | $1.00 | $0.88 | $0.75 | $-1.55 | $0.28 | $1.39 | $0.23 | $0.48 | $0.22 | $0.11 | $-0.06 | |
| Shares (Basic) | 39,353,965 | 39,275,424 | · | 39,078,378 | 38,834,917 | 38,562,191 | · | 38,610,805 | 38,793,341 | 38,717,334 | 38,628,565 | 38,462,463 | 38,320,999 | 38,186,342 | 38,030,344 | 37,918,452 | |
| Shares (Diluted) | 39,572,059 | 39,543,780 | · | 39,302,239 | 39,245,953 | 39,163,428 | · | 39,178,227 | 38,793,341 | 39,387,359 | 39,291,044 | 39,219,966 | 39,201,155 | 39,075,388 | 38,896,940 | 37,918,452 | |
| EBITDA | $41M | $43M | · | $49M | $41M | $45M | · | $35M | $-81M | $20M | · | $13M | $18M | $15M | · | $5M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $241M | $187M | $321M | $422M | $376M | $324M | $280M | $288M | $223M | · | $101M | $114M | $95M | · | $55M | |
| Receivables | $190M | $183M | $190M | $183M | $176M | $168M | $168M | $176M | $201M | $192M | · | $207M | $209M | $207M | · | $189M | |
| Inventory | $443M | $439M | $432M | $432M | $428M | $416M | $407M | $393M | $374M | $398M | · | $374M | $359M | $344M | · | $320M | |
| Prepaid Expense | $52M | $38M | $50M | $55M | $38M | $37M | $37M | $31M | $29M | $31M | · | $39M | $39M | $36M | · | $30M | |
| Current Assets | $1.34B | $1.28B | $1.22B | $1.14B | $1.07B | $1000M | $951M | $892M | $944M | $935M | · | $868M | $828M | $786M | · | $724M | |
| PP&E (Net) | $147M | $134M | $117M | $98M | $85M | $72M | $63M | $60M | $58M | $76M | · | $66M | $66M | $65M | · | $64M | |
| PP&E (Gross) | · | · | $194M | · | · | · | $137M | $132M | $143M | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $77M | · | · | · | $74M | $72M | $85M | · | · | · | · | · | · | · | |
| Goodwill | $167M | $167M | $167M | $167M | $167M | $166M | $166M | $166M | $166M | $166M | · | $166M | $166M | $166M | · | $165M | |
| Intangibles | $6M | $6M | $6M | $6M | $7M | $6M | $7M | $7M | $7M | $68M | · | $73M | $76M | $79M | · | $83M | |
| Other Non-current Assets | $41M | $41M | $41M | $40M | $40M | $44M | $41M | $39M | $39M | $34M | · | $15M | $10M | $11M | · | $13M | |
| Total Assets | $1.97B | $1.90B | $1.83B | $1.74B | $1.67B | $1.59B | $1.53B | $1.48B | $1.53B | $1.58B | · | $1.47B | $1.43B | $1.40B | · | $1.32B | |
| Accounts Payable | $45M | $44M | $35M | $30M | $28M | $31M | $31M | $33M | $33M | $32M | · | $28M | $26M | $28M | · | $25M | |
| Accrued Liabilities | $172M | $152M | $132M | $124M | $114M | $113M | $112M | $106M | $104M | $107M | · | $104M | $106M | $106M | · | $102M | |
| Current Liabilities | $234M | $212M | $183M | $170M | $158M | $159M | $158M | $153M | $151M | $153M | · | $145M | $144M | $146M | · | $138M | |
| Capital Leases | $176M | $179M | $183M | $180M | $183M | $185M | $187M | $190M | $192M | $195M | · | $192M | $195M | $197M | · | $181M | |
| Other Non-current Liabilities | $14M | $13M | $12M | $15M | $18M | $16M | $15M | $9M | $8M | $6M | · | $3M | $3M | $3M | · | $3M | |
| Total Liabilities | $444M | $425M | $399M | $386M | $381M | $380M | $382M | $375M | $373M | $376M | · | $364M | $366M | $371M | · | $348M | |
| Common Stock | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $38.0K | $38.0K | $39.0K | $39.0K | · | $38.0K | $38.0K | $38.0K | · | $38.0K | |
| Paid-in Capital | $1.22B | $1.20B | $1.19B | $1.17B | $1.15B | $1.12B | $1.10B | $1.08B | $1.08B | $1.06B | · | $1.03B | $1.00B | $979M | · | $947M | |
| Retained Earnings | $305M | $270M | $238M | $190M | $144M | $99M | $60M | $26M | $86M | $146M | · | $81M | $71M | $52M | · | $40M | |
| AOCI | $1M | $2M | $4M | $3M | $3M | $-3M | $-6M | $-963.0K | $-5M | $-5M | · | $-7M | $-6M | $-7M | · | $-13M | |
| Stockholders' Equity | $1.53B | $1.47B | $1.43B | $1.36B | $1.29B | $1.21B | $1.15B | $1.10B | $1.16B | $1.20B | $1.18B | $1.10B | $1.07B | $1.02B | $999M | $974M | |
| Liabilities + Equity | $1.97B | $1.90B | $1.83B | $1.74B | $1.67B | $1.59B | $1.53B | $1.48B | $1.53B | $1.58B | · | $1.47B | $1.43B | $1.40B | · | $1.32B | |
| Shares Outstanding | · | · | 39,229,670 | · | · | · | 38,490,836 | · | · | · | · | · | · | · | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $5M | $4M | $2M | $6M | $5M | $4M | $4M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | |
| Stock-based Comp | $14M | $15M | $15M | $16M | $14M | $14M | $12M | $11M | $10M | $14M | $11M | $14M | $13M | $13M | $10M | $10M | |
| Amort. of Intangibles | $181.0K | $182.0K | $182.0K | $182.0K | $178.0K | $170.0K | $170.0K | $176.0K | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Restructuring | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $35M | · | · | · | $-9M | · | · | · | $6M | · | · | · | $-15M | · | · | |
| Operating Cash Flow | $46M | $87M | $86M | $58M | $45M | $49M | $51M | $56M | $23M | $38M | $36M | $31M | $17M | $13M | $1M | $-13M | |
| CapEx | $14M | $14M | $18M | $16M | $16M | $13M | $5M | $5M | $5M | $6M | $4M | $3M | $4M | $4M | $4M | $6M | |
| Investing Cash Flow | $-91M | $-31M | $-226M | $-163M | $-16M | $-502.0K | $-11M | $36M | $34M | $18M | $24M | $-44M | $-7M | $11M | $9M | $10M | |
| Stock Repurchased | · | · | $0 | · | · | · | $-1.0K | · | · | · | $0 | · | · | · | · | · | |
| Financing Cash Flow | $9M | $-2M | $5M | $4M | $15M | $3M | $6M | $-101M | $8M | $-794.0K | $6M | $212.0K | $9M | $1M | $6M | $-603.0K | |
| Net Change in Cash | $-36M | $54M | $-134M | $-101M | $46M | $52M | $44M | $-8M | $65M | $56M | $67M | $-13M | $19M | $25M | $15M | $-3M | |
| Free Cash Flow | · | $73M | · | · | · | $36M | · | · | · | $32M | · | · | · | $9M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $32M | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.9% | 67.6% | · | 67.8% | 66.0% | 66.6% | · | 66.5% | 54.4% | 65.0% | · | 65.6% | 63.8% | 62.6% | · | 63.3% | |
| Operating Margin | 10.5% | 10.2% | · | 13.8% | 12.0% | 12.4% | · | 11.8% | -27.0% | 4.3% | · | 4.7% | 6.8% | 3.3% | · | 2.5% | |
| Net Margin | 8.9% | 8.7% | · | 12.9% | 13.3% | 12.1% | · | 9.8% | -20.1% | 4.0% | · | 3.4% | 7.2% | 3.5% | · | -1.1% | |
| Pretax Margin | 11.8% | 11.1% | · | 14.8% | 13.4% | 13.5% | · | 13.2% | -26.0% | 5.2% | · | 4.9% | 7.5% | 3.6% | · | 1.4% | |
| EBITDA Margin | 10.5% | 11.4% | · | 13.8% | 12.0% | 14.0% | · | 11.8% | -27.0% | 7.0% | · | 4.7% | 6.8% | 6.0% | · | 2.5% | |
| ROA | 1.9% | 1.9% | · | 2.8% | 2.8% | 2.5% | · | 2.0% | -4.1% | 0.74% | · | 0.66% | 1.4% | 0.63% | · | -0.20% | |
| ROE | 2.5% | 2.4% | · | 3.7% | 3.7% | 3.2% | · | 2.7% | -5.4% | 0.99% | · | 0.89% | 1.9% | 0.86% | · | -0.27% | |
| ROIC | 2.0% | 2.0% | · | 3.1% | 3.2% | 3.0% | · | 2.4% | -5.4% | 0.76% | · | 0.79% | 1.6% | 0.77% | · | -0.42% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 6.0 | · | 6.7 | 6.8 | 6.3 | · | 5.8 | 6.3 | 6.1 | · | 6.0 | 5.7 | 5.4 | · | 5.2 | |
| Quick Ratio | 1.7 | 2.0 | · | 3.0 | 3.8 | 3.4 | · | 3.0 | 3.2 | 2.7 | · | 2.1 | 2.2 | 2.1 | · | 1.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -235.4 | 30.1 | · | · | · | · | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 2.1 | 2.1 | · | 2.0 | 1.8 | 1.8 | · | 1.6 | 1.5 | 1.4 | · | 1.4 | 1.3 | 1.4 | · | 1.4 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $9.86 | $9.48 | · | $9.02 | $8.65 | $8.28 | · | $7.68 | $7.72 | $7.07 | · | $6.91 | $6.67 | $6.18 | · | $5.64 | |
| Cash Flow / Share | · | $2.20 | · | · | · | $1.25 | · | · | · | $0.97 | · | · | · | $0.34 | · | · | |
| EPS (TTM) | $4.07 | $4.34 | · | $4.20 | $3.78 | $1.08 | · | $0.87 | $0.35 | $2.38 | · | $1.04 | $0.75 | $0.17 | · | $-0.83 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.50B | $1.45B | · | $1.33B | $1.28B | $1.24B | · | $1.16B | $1.13B | $1.10B | · | $995M | $938M | $885M | · | $830M | |
| Net Income TTM | $161M | $171M | · | $164M | $148M | $42M | · | $35M | $14M | $93M | · | $41M | $29M | $6M | · | $-31M | |
| P/E | 77.6 | 75.7 | · | 60.3 | 67.9 | 247.6 | · | 223.3 | 514.2 | 93.8 | · | 232.6 | 458.7 | 1639.4 | · | -228.4 | |
| Earnings Yield | 1.3% | 1.3% | · | 1.7% | 1.5% | 0.40% | · | 0.45% | 0.19% | 1.1% | · | 0.43% | 0.22% | 0.06% | · | -0.44% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $1.40B | $1.19B | $1.06B | $847M | $748M |
| Gross Margin % | 67.1% | 63.2% | 64.5% | 63.2% | 63.6% |
| Operating Margin % | 13.5% | 0.78% | 7.0% | 0.72% | -1.0% |
| Net Income | $178M | $14M | $91M | $-2M | $5M |
| Diluted EPS | $4.52 | $0.36 | $2.32 | $-0.05 | $0.14 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 6.6 | 6.0 | 6.1 | 5.2 | 5.5 |
| Quick Ratio | 2.1 | 3.1 | 2.4 | 1.9 | 1.6 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $175M | $147M | $82M | $-75M | $-12M |
Institutional owners (13F) 490 filers · $12.1B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
490
Value held
$12.1B
New positions
46
Exited positions
67
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 46 (-96 vs prior Q) | 67 (-9 vs prior Q) | 148 (-1 vs prior Q) | 186 (+50 vs prior Q) | +877K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $1,356,952,992 | 4,297,555 | 11.19% | Shares |
| VANGUARD GROUP INC | $1,172,307,607 | 3,770,569 | 9.67% | Shares |
| HBK INVESTMENTS L P | $580,508,901 | 1,838,508 | 4.79% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $539,893,663 | 1,709,877 | 4.45% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $526,442,397 | 1,667,276 | 4.34% | Shares |
| STATE STREET CORP | $392,556,505 | 1,243,258 | 3.24% | Shares |
| ExodusPoint Capital Management, LP | $344,303,272 | 1,090,430 | 2.84% | Shares |
| Balyasny Asset Management L.P. | $344,218,967 | 1,090,163 | 2.84% | Shares |
| JPMORGAN CHASE & CO | $338,557,982 | 1,071,454 | 2.79% | Shares |
| GOLDMAN SACHS GROUP INC | $267,473,088 | 847,104 | 2.21% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $263,620,622 | 834,903 | 2.17% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $251,546,090 | 796,471 | 2.07% | Shares |
| NORGES BANK | $237,520,412 | 752,242 | 1.96% | Shares |
| UBS Group AG | $222,231,798 | 703,822 | 1.83% | Shares |
| MILLENNIUM MANAGEMENT LLC | $221,217,923 | 700,611 | 1.82% | Shares |
| MORGAN STANLEY | $186,869,151 | 591,824 | 1.54% | Shares |
| AQR Arbitrage LLC | $178,042,900 | 563,873 | 1.47% | Shares |
| WHITEBOX ADVISORS LLC | $160,047,676 | 506,881 | 1.32% | Shares |
| Capital World Investors | $151,465,591 | 479,701 | 1.25% | Shares |
| CITADEL ADVISORS LLC | $141,696,917 | 448,763 | 1.17% | Shares |
| NEUBERGER BERMAN GROUP LLC | $138,473,110 | 438,553 | 1.14% | Shares |
| CITIGROUP INC | $136,759,219 | 433,125 | 1.13% | Shares |
| TWO SIGMA INVESTMENTS, LP | $135,181,416 | 428,128 | 1.11% | Shares |
| TUDOR INVESTMENT CORP ET AL | $126,504,922 | 400,649 | 1.04% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $108,527,380 | 343,713 | 0.89% | Shares |
| NORTHERN TRUST CORP | $105,164,958 | 333,064 | 0.87% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $102,972,179 | 326,120 | 0.85% | Shares |
| ALLIANCEBERNSTEIN L.P. | $99,031,466 | 301,585 | 0.82% | Shares |
| BANK OF AMERICA CORP /DE/ | $83,994,867 | 266,017 | 0.69% | Shares |
| Invesco Ltd. | $83,351,684 | 263,980 | 0.69% | Shares |
| Magnetar Financial LLC | $80,781,796 | 255,841 | 0.67% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $79,488,800 | 251,746 | 0.66% | Shares |
| Bank of New York Mellon Corp | $74,304,811 | 235,328 | 0.61% | Shares |
| Champlain Investment Partners, LLC | $69,159,354 | 219,032 | 0.57% | Shares |
| TIG Advisors, LLC | $67,912,141 | 215,082 | 0.56% | Shares |
| LMR Partners LLP | $67,536,715 | 213,893 | 0.56% | Shares |
| FMR LLC | $66,623,786 | 211,002 | 0.55% | Shares |
| Hudson Bay Capital Management LP | $64,140,823 | 203,138 | 0.53% | Shares |
| MILLENNIUM MANAGEMENT LLC | $63,150,000 | 200,000 | 0.52% | Put option |
| D. E. Shaw & Co., Inc. | $62,306,632 | 197,329 | 0.51% | Shares |
| ALPINE ASSOCIATES MANAGEMENT INC. | $59,672,330 | 188,986 | 0.49% | Shares |
| Melqart Asset Management (UK) Ltd | $58,645,511 | 185,734 | 0.48% | Shares |
| CAXTON ASSOCIATES LLP | $56,640,498 | 179,384 | 0.47% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $55,799,340 | 176,720 | 0.46% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $55,540,425 | 175,900 | 0.46% | Put option |
| JANUS HENDERSON GROUP PLC | $54,849,328 | 167,054 | 0.45% | Shares |
| Birnam Oak Advisors, LP | $54,080,713 | 171,277 | 0.45% | Shares |
| Westchester Capital Management, LLC | $49,721,784 | 157,472 | 0.41% | Shares |
| WATER ISLAND CAPITAL LLC | $47,506,483 | 150,456 | 0.39% | Shares |
| Woodline Partners LP | $46,050,243 | 145,844 | 0.38% | Shares |
Company insiders 19 insiders · 5 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Adam Elsesser | CEO | May 19, 2026 G | 683,042 | 0 | 0 | $0 |
| Maggie Yuen | Chief Financial Officer | March 15, 2026 F | 18,167 | 0 | 1 | $-832,474 |
| Shruthi Narayan | President | Sept. 15, 2026 F | 32,650 | 0 | 0 | $0 |
| Lambert Shiu | Chief Accounting Officer | March 15, 2026 F | 39,323 | 0 | 0 | $0 |
| Johanna Roberts | EVP, Gen. Counsel & Secretary | March 15, 2026 F | 67,298 | 0 | 29 | $-1,117,125 |
| Surbhi Sarna | Director | Feb. 13, 2026 A | 4,293 | 0 | 0 | $0 |
| Janet Leeds | Director | Feb. 13, 2026 A | 6,639 | 0 | 0 | $0 |
| Bridget O'Rourke | Director | Feb. 13, 2026 A | 5,962 | 0 | 0 | $0 |
| Arani Bose | Director | Feb. 13, 2026 A | 1,147 | 0 | 10 | $-9,062,931 |
| Thomas Wilder | Director | Feb. 13, 2026 A | 589 | 0 | 2 | $-105,025 |
| Walter Charles Wang | Director | March 4, 2016 A | 521,071 | 0 | 0 | $0 |
| Harpreet Grewal | · | April 2, 2026 S | 8,719 | 0 | 5 | $-208,842 |
| Don W. Kassing | · | Feb. 14, 2025 A | 1,409 | 0 | 0 | $0 |
| James Robert Pray | · | Oct. 1, 2021 S | 408,431 | 0 | 0 | $0 |
| Lynn Rothman | · | Oct. 1, 2021 M | 32,637 | 0 | 0 | $0 |
| Sridhar Kosaraju | · | April 15, 2020 S | 155,351 | 0 | 0 | $0 |
| Daniel Donen Davis | · | Dec. 27, 2018 M | 64,277 | 0 | 0 | $0 |
| Robert D. Evans | · | Aug. 30, 2018 M | 15,667 | 0 | 0 | $0 |
| Kevin James Sullivan | · | Aug. 31, 2016 S | 29,449 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 67 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| RSBA · Tidal Trust II | 4.65% | 7,617 NS | July 31, 2026 | N-PORT |
| NEWZ · EA Series Trust | 3.43% | 2,085 NS | July 31, 2026 | N-PORT |
| MNA · New York Life Investments ETF Trust | 2.11% | 16,553 NS | July 31, 2026 | N-PORT |
| IHI · iShares Trust | 1.88% | 188,033 SH | Sept. 11, 2026 | Daily |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.65% | 3,558 NS | July 31, 2026 | N-PORT |
| RFG · Invesco Exchange-Traded Fund Trust | 0.96% | 9,963 SH | Sept. 30, 2026 | Daily |
| MEDI · Harbor ETF Trust | 0.77% | 987 NS | July 31, 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.65% | 38,809 SH | Aug. 19, 2026 | Daily |
| IQSM · New York Life Investments ETF Trust | 0.46% | 4,773 NS | July 31, 2026 | N-PORT |
| PAMC · Pacer Funds Trust | 0.43% | 712 NS | July 31, 2026 | N-PORT |
| ISCG · iShares Trust | 0.40% | 12,024 SH | Sept. 11, 2026 | Daily |
| NUSC · Nushares ETF Trust | 0.39% | 15,774 NS | July 31, 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0.36% | 4,350 NS | July 31, 2026 | N-PORT |
| IWP · iShares Trust | 0.36% | 214,670 SH | Sept. 11, 2026 | Daily |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.34% | 63,544 SH | Aug. 19, 2026 | Daily |
| VBK · VANGUARD INDEX FUNDS | 0.32% | 495,123 SH | Aug. 19, 2026 | Daily |
| BKMC · BNY Mellon ETF Trust | 0.31% | 6,335 NS | July 31, 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.30% | 4,348 NS | July 31, 2026 | N-PORT |
| SMDX · Tidal Trust III | 0.29% | 1,182 NS | July 31, 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.27% | 578 NS | July 31, 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.26% | 16,632 NS | July 31, 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.23% | 18,226 NS | July 31, 2026 | N-PORT |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0.20% | 50,475 NS | July 31, 2026 | N-PORT |
| IYH · iShares Trust | 0.19% | 22,263 SH | Sept. 11, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.17% | 17,746 NS | July 31, 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0.17% | 13,412 NS | July 31, 2026 | N-PORT |
| ESML · iShares Trust | 0.17% | 15,152 SH | Sept. 11, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.17% | 112,334 SH | Aug. 19, 2026 | Daily |
| SMMD · iShares Trust | 0.17% | 20,300 SH | Sept. 11, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.15% | 12,580 SH | Sept. 30, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.14% | 451,358 SH | Aug. 19, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.14% | 856,800 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.12% | 59,193 NS | July 31, 2026 | N-PORT |
| WSML · iShares Trust | 0.11% | 2,287 SH | Sept. 11, 2026 | Daily |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 2,371 SH | Oct. 1, 2026 | Daily |
| IWR · iShares Trust | 0.09% | 156,309 SH | Sept. 11, 2026 | Daily |
| RILA · Spinnaker ETF Series | 0.07% | 88 NS | July 31, 2026 | N-PORT |
| XT · iShares Trust | 0.07% | 8,117 SH | Sept. 11, 2026 | Daily |
| RWK · Invesco Exchange-Traded Fund Trust … | 0.06% | 2,477 SH | Oct. 1, 2026 | Daily |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0.04% | 60,327 SH | Aug. 19, 2026 | Daily |
| IWF · iShares Trust | 0.04% | 143,096 SH | Sept. 11, 2026 | Daily |
| IUSG · iShares Trust | 0.03% | 35,012 SH | Sept. 11, 2026 | Daily |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.03% | 3,843 SH | Oct. 1, 2026 | Daily |
| TILT · FlexShares Trust | 0.02% | 1,422 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.02% | 1,186,275 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.02% | 6,349 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.02% | 3,208 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.02% | 8,611 SH | Aug. 19, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.02% | 27,709 NS | July 31, 2026 | N-PORT |
| IYY · iShares Trust | 0.02% | 1,685 SH | Sept. 10, 2026 | Daily |
| IWB · iShares Trust | 0.02% | 26,117 SH | Sept. 11, 2026 | Daily |
| ITOT · iShares Trust | 0.02% | 50,889 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.02% | 10,594 SH | Sept. 10, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.02% | 6,022 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.02% | 9,928 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 1,400 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.01% | 810 NS | July 31, 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 30,658 SH | Aug. 19, 2026 | Daily |
| EPU · iShares Trust | 0.00% | 19,935 SH | Sept. 11, 2026 | Daily |
| DYNF · BlackRock ETF Trust | 0.00% | 42 SH | Aug. 24, 2026 | Daily |
| EEMS · iShares, Inc. | 0.00% | 100 SH | Aug. 26, 2026 | Daily |
| IJH · iShares Trust | · | 1,380,497 SH | Sept. 11, 2026 | Daily |
| IJK · iShares Trust | · | 228,092 SH | Sept. 11, 2026 | Daily |
| XJH · iShares Trust | · | 5,373 SH | Sept. 8, 2026 | Daily |
| ISCB · iShares Trust | · | 1,708 SH | Sept. 11, 2026 | Daily |
| SMLF · iShares Trust | · | 10,495 SH | Sept. 11, 2026 | Daily |
| SMMV · iShares Trust | · | 5,954 SH | Sept. 1, 2026 | Daily |
PEN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 20 analysts
HOLD
Median target
$374.00
+17.8%
1 5.0%
Strong Buy
5 25.0%
Buy
14 70.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
12 analysts · 2026-10-02Mean target $361.83 +13.9%
← Below all targets
Current price $317.55
Low$323.00
Mean$361.83
High$374.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
| TFX | · | -6.0 | 17.2% | -45.5% | -24.6% | 56.2% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Jul 30, 2026